Maoxin Ran
University of Macau(MO)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, ATP Synthase and ATPases Research, Cancer-related Molecular Pathways, Bioinformatics and Genomic Networks, Ubiquitin and proteasome pathways
Most-Cited Works
- → Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing(2023)34 cited
- → Epigallocatechin gallate circumvents drug‐induced resistance in non‐small‐cell lung cancer by modulating glucose metabolism and AMPK/AKT/MAPK axis(2023)26 cited
- → Dichloroacetophenone biphenylsulfone ethers as anticancer pyruvate dehydrogenase kinase inhibitors in non-small cell lung cancer models(2023)14 cited
- → Cytosolic malic enzyme and glucose‐6‐phosphate dehydrogenase modulate redox balance in NSCLC with acquired drug resistance(2023)9 cited
- → Targeting hexokinase 2 to enhance anticancer efficacy of trichosanthin in HeLa and SCC25 cell models(2024)3 cited
- → Suppressing protein damage response to overcome multidrug resistance in cancer therapy(2025)2 cited
- → A critical role of protein damage response in mediating cancer drug resistance(2024)1 cited
- → Identifying meaningful drug response biomarkers from public pharmacogenomic datasets with biologically informed interpretable neural networks(2025)
- → Targeting Metabolic Vulnerabilities Reveals Hexokinase 2 as a Key Mediator of Resistance to Osimertinib in Non-Small Cell Lung Cancer Models(2025)
- → Low dose radiation induces new protein synthesis that promotes cancer radiotherapy resistance(2026)